Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Reinvestment Rate
Henan Taloph Pharmaceutical Stock Co Ltd cash flow reinvestment rate. Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow Reinvestment Rate of 0.24x as of September 2025, reinvesting CN¥5.45 Million (capex CN¥5.45 Million ) from operating cash flow of CN¥22.69 Million. Explore debt repayment capacity of Henan Taloph Pharmaceutical Stock Co Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Cash flow reinvestment rate of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. Historical reinvestment intensity for Henan Taloph Pharmaceutical Stock Co Ltd across 24 annual periods. Explore Henan Taloph Pharmaceutical Stock Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Reinvestment Rate by Year (1998–2025)
Henan Taloph Pharmaceutical Stock Co Ltd cash flow reinvestment rate by year from 1998 to 2025. Year-by-year capital reinvestment analysis for Henan Taloph Pharmaceutical Stock Co Ltd. For the full cash flow conversion analysis, see 600222 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.90x | CN¥42.25 Million | CN¥47.16 Million | CN¥21.12 Million | ▼ -74.2% |
| 2023 | 3.48x | CN¥152.04 Million | CN¥43.74 Million | CN¥43.13 Million | ▲ +173.3% |
| 2021 | 1.27x | CN¥126.74 Million | CN¥99.66 Million | CN¥39.07 Million | ▼ -51.6% |
| 2020 | 2.63x | CN¥192.82 Million | CN¥73.43 Million | CN¥72.65 Million | ▼ -31.7% |
| 2019 | 3.84x | CN¥159.55 Million | CN¥41.53 Million | CN¥107.68 Million | ▲ +378.1% |
| 2018 | 0.80x | CN¥96.01 Million | CN¥119.47 Million | CN¥66.41 Million | ▼ -87.2% |
| 2017 | 6.27x | CN¥145.19 Million | CN¥23.17 Million | CN¥44.34 Million | ▲ +484.4% |
| 2016 | 1.07x | CN¥75.70 Million | CN¥70.60 Million | CN¥59.60 Million | ▼ -48.6% |
| 2015 | 2.08x | CN¥102.71 Million | CN¥49.27 Million | CN¥62.04 Million | ▲ +424.0% |
| 2014 | 0.40x | CN¥35.62 Million | CN¥89.54 Million | CN¥35.62 Million | ▲ +133.4% |
| 2012 | 0.17x | CN¥14.91 Million | CN¥87.45 Million | CN¥14.91 Million | ▼ -100.0% |
| 2011 | 612.28x | CN¥64.41 Million | CN¥105.20K | CN¥64.41 Million | ▲ +46377.1% |
| 2009 | 1.32x | CN¥28.25 Million | CN¥21.45 Million | CN¥28.25 Million | ▼ -41.7% |
| 2008 | 2.26x | CN¥40.98 Million | CN¥18.13 Million | CN¥40.98 Million | ▲ +13.7% |
| 2007 | 1.99x | CN¥42.42 Million | CN¥21.34 Million | CN¥42.42 Million | ▼ -91.4% |
| 2006 | 22.99x | CN¥36.64 Million | CN¥1.59 Million | CN¥36.64 Million | ▼ -69.0% |
| 2005 | 74.04x | CN¥20.46 Million | CN¥276.30K | CN¥20.46 Million | ▲ +8971.7% |
| 2004 | 0.82x | CN¥14.90 Million | CN¥18.25 Million | CN¥14.90 Million | ▼ -81.9% |
| 2003 | 4.52x | CN¥16.89 Million | CN¥3.74 Million | CN¥16.89 Million | ▲ +430.5% |
| 2002 | 0.85x | CN¥6.36 Million | CN¥7.47 Million | CN¥6.36 Million | ▼ -20.2% |
| 2001 | 1.07x | CN¥58.73 Million | CN¥55.03 Million | CN¥58.73 Million | ▼ -99.1% |
| 2000 | 123.50x | CN¥108.11 Million | CN¥875.36K | CN¥108.11 Million | ▲ +15260.6% |
| 1999 | 0.80x | CN¥79.86 Million | CN¥99.32 Million | CN¥79.86 Million | ▲ +63076.1% |
| 1998 | 0.00x | CN¥35.69K | CN¥28.04 Million | CN¥35.69K | — |